Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment
Bun-Hee Lee,1 Young-Min Park,2 Tae Hyun Um,3 Sollip Kim3 1Department of Psychiatry, Gangnam Eulji Hospital, Eulji University, Seoul, 2Department of Psychiatry, 3Department of Laboratory Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South Korea Background: Remission,...
Saved in:
Main Authors: | Lee BH, Park YM, Um TH, Kim S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/b5d55e3d91e948ada3e09aa3e30367cf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
by: Saragoussi D, et al.
Published: (2017) -
Comparative efficacy of escitalopram in the treatment of major depressive disorder
by: Mazen K Ali, et al.
Published: (2011) -
Brain-derived neurotrophic factor: role in depression and suicide
by: Yogesh Dwivedi
Published: (2009) -
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
by: Kishi T, et al.
Published: (2017) -
Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
by: Maneeton B, et al.
Published: (2018)